When analyzed without regard to nodal involvement, patients with stage T1-T4 HNSCC have an increase in the percentage of CD34+ cells in the peripheral blood mononuclear cell population as compared to control patients, with no difference seen among groups with various stages of HNSCC [17]. The gene discussed is CD34; the disease is head and neck squamous cell carcinoma.